Cite
HARVARD Citation
Wang, N. et al. (2021). CTIM-01. PHASE II TRIAL OF PEMBROLIZUMAB AND LENVATINIB FOR LEPTOMENINGEAL METASTASES. Neuro-oncology. pp. vi48-vi49. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, N. et al. (2021). CTIM-01. PHASE II TRIAL OF PEMBROLIZUMAB AND LENVATINIB FOR LEPTOMENINGEAL METASTASES. Neuro-oncology. pp. vi48-vi49. [Online].